New Medicines in Diabetes overview and update

This talk will consider the new evidence released in 2018 and the upcoming evidence due in 2019 and how this is influencing the place of drugs in treatment decisions. It will discuss how newer classes of medication are being considered outside of purely glucose management and encouraging a move toward thinking more holistic and individualised treatment discussions related to co-morbid renal and cardiovascular disease. By understanding the evidence we can understand how guidance may change and how we as pharmacists can support our patients and our colleagues to make the best evidence based decision.

Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and works at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee, the Joint British Diabetes Societies (JBDS-IP) Group and Chairs the regional Diabetic subgroup of the District Prescribing Committee. At Southampton he is the clinical lead for type 1 diabetes and as an interest in severe insulin resistance.

At a national level he is the lead pharmacist for NHS England Diabetes and Endocrinology Clinical Reference Group, is a member of the Diabetes UK professional council and sits on the Diabetes Parliamentary Think Tank. He is also an editorial board member of “Diabetes in Primary Care”, the “Journal of Medicines Optimisation” and “Medicine Matters diabetes”.  He is also a specialist advisor to the CQC for diabetes in secondary and intermediate care services.  In 2015 he was awarded the National Leadership in Pharmacy award by the Royal Pharmaceutical Society.

He has a key role with pharmaceutical and clinical input into the direction of inpatient and outpatient diabetes care at University Hospital Southampton, and works in a Consultant practitioner prescribing Pharmacist role on a day to day basis reviewing inpatients and outpatients with diabetes and endocrine issues. His dedication to education ensures the rest of his time is taken up educating doctors, nurses, allied healthcare professionals and students within secondary care, primary care and university settings.  He is the MSc module lead for “Modern Management of Diabetes, Nutrition and Pharmacotherapy” at the University of Southampton.